How much does UPTRAVI (Selexipag Tablets) Cost& price without insurance in China?
UPTRAVI® is the commercial brand name of Selexipag Tablets, an orally active selective prostacyclin IP-receptor agonist developed by Janssen. It selectively activates prostacyclin receptor on pulmonary vasculature to dilate pulmonary artery and inhibit vascular remodeling, delaying PAH progression.UPTRAVI
Main Indications
Treatment of adult pulmonary arterial hypertension (PAH, WHO Group Ⅰ, functional class Ⅱ–Ⅲ), to slow disease progression and reduce PAH-related hospitalization risk.UPTRAVI
Common Side Effects
Common mild adverse reactions: Headache, diarrhea, jaw pain, flushing, nausea and myalgia.
Laboratory abnormalities: Rare transient liver enzyme elevation.
Severe but manageable risks: Severe hypotension and hypersensitivity reactions.
Approval Status in China
UPTRAVI® (Selexipag Tablets, 0.8mg, domestic Chinese brand name: Youtuobi) was officially approved for marketing in China in 2018. It is currently a prescription drug included in China’s Category B medical insurance.
Buy UPTRAVI (Selexipag Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
